Winslow Capital Management, LLC Insulet Corp Transaction History

Winslow Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$225.52 - $304.06 $162 Million - $218 Million	-716,255 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$235.95 - $293.05 $106 Million - $132 Million	450,706 Added 169.73%	716,255 $187 Million
Q4 2020 Feb 12, 2021	BUY	$215.97 - $265.89 $57.4 Million - $70.6 Million	265,549 New	265,549 $67.9 Million

696

62.6M

640K

841K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $19.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Winslow Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Winslow Capital Management, LLC with notifications on news.